Virtual Incision Receives FDA 510(k) Clearance for the MIRA™ Surgical System in Benign Hysterectomy Procedures

LINCOLN, Neb.  — August 25, 2026 - Virtual Incision Corporation, developer of the MIRA™ Surgical System (MIRA), today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the use of MIRA in benign hysterectomy procedures. MIRA received De Novo authorization for use in adults undergoing colectomy procedures in February 2024 as the world's first miniaturized robotic-assisted surgery (miniRAS) device.

Click here to read the full story.

To access a PDF of the story click here.

Virtual Incision Corporation - Shared by Tyler Stowater, board member of Virtual Incision Corporation